Table 3.
A 31-year-old female was diagnosed with acute myeloid leukemia (AML) approximately 3 months after experiencing COVID-19. Results of her complete blood count with the differential before the SARS-CoV-2 infection and at admission to the Hematology Unit are indicated.
| Laboratory study | Value before COVID-19 | Value at admission to the Hematology Unit |
|---|---|---|
| Hemoglobin (g/dL) | 12.8 | 8.2 |
| Hematocrit (%) | 38.8 | 24.6 |
| Mean corpuscular volume (fL) | 94.6 | 95.2 |
| Mean corpuscular hemoglobin (pg) | 31.2 | 33.6 |
| Leukocyte count (cells/µL) | 6,370 | 3669 |
| Blast cells (cells/µL) | 0 | 880 |
| Neutrophils (cells/µL) | 3,166 | 1320 |
| Lymphocytes (cells/µL) | 2,484 | 1447 |
| Monocytes (cells/µL) | 420 | 22 |
| Eosinophils (cells/µL) | 287 | 0 |
| Basophils (cells/µL) | 13 | 0 |
| Platelet count (cells/µL) | 275,000 | 66,350 |